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Abstract
OBJECTIVE—To better understand the current evaluation of unexplained menorrhagia by 
obstetrician-gynecologists and the extent to which a bleeding disorder diagnosis is being 
considered in this population.
STUDY DESIGN—A total of 1200 Fellows and Junior Fellows of the American College of 
Obstetricians and Gynecologists were invited to participate in a survey on blood disorders. 
Respondents completed a questionnaire regarding their patient population and their evaluation of 
patients with unexplained menorrhagia.
RESULTS—The overall response rate was 42.4%. Eighty-two percent of respondents reported 
having seen patients with menorrhagia caused by a bleeding disorder. Seventy-seven percent of 
physicians reported they would be likely or very likely to consider a bleeding disorder as causing 
menorrhagia in adolescent patients; however, only 38.8% would consider bleeding disorders in 
reproductive age women.
CONCLUSION—The current data demonstrate that obstetrician-gynecologists seem to have a 
relatively high awareness of bleeding disorders as a potential underlying cause of menorrhagia.
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Menorrhagia is a common clinical problem that affects approximately 30% of reproductive-
age women.1 Menorrhagia may result from various clinical conditions, including uterine 
fibroids, endometriosis, and cancer; however, a cause for menorrhagia is never identified in 
approximately 50% of cases.2 Underlying bleeding disorders, including von Willebrand 
disease (VWD), other coagulation factor deficiencies, and platelet disorders, are prevalent 
among women with menorrhagia. VWD is caused by a quantitative or qualitative defect in 
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von Willebrand factor (VWF) that interferes with the localization of platelets to the site of 
bleeding. VWD is the most common bleeding disorder; the estimated prevalence is 
approximately 1% worldwide.3 Recent studies indicate that between 5% and 24% of women 
with menorrhagia had previously undiagnosed VWD.4 Conversely,menorrhagiaisthemost 
prevalent symptom among women with VWD; 32-100% of women with VWD reported 
menorrhagia.5 VWD and other bleeding disorders have been associated with increased 
obstetric and gynecologic morbidity, including endometriosis, miscarriage, and postpartum 
hemorrhage.5
Obstetrician-gynecologists are usually the first health care providers to encounter women 
with menorrhagia. Studies in the US and UK indicate that obstetrician-gynecologists may be 
unlikely to consider an underlying bleeding disorder as the cause of unexplained 
menorrhagia.6,7 Early identification is important to prevent adverse bleeding events and 
reduce potentially unnecessary surgical interventions. Studies have shown that women with 
VWD are more likely to undergo hysterectomy and are significantly more likely to 
experience surgical bleeding complications8,9; these complications could be avoided with 
accurate and timely diagnosis.
The current study was conducted to assess the current state of knowledge of bleeding 
disorders and practice patterns of obstetrician-gynecologists to better understand the current 
evaluation of unexplained menorrhagia by obstetrician-gynecologists, and the extent to 
which a bleeding disorder diagnosis is being considered in this population.
MATERIALS AND METHODS
In December 2009, the American College of Obstetricians and Gynecologists (ACOG) sent 
survey questionnaires to 1200 Fellows and Junior Fellows in practice. Six hundred of the 
recipients were members of the Collaborative Ambulatory Research Network (CARN), a 
group of practicing obstetrician-gynecologists who volunteer to participate in survey 
research. The remaining 600 recipients were not CARN members and were randomly 
selected from College Fellows and Junior Fellows in practice. Three additional mailings of 
the survey were administered before a Fellow was considered a nonresponder. The study 
was approved by the ACOG institutional review board.
The survey included questions about physician characteristics, current practice 
characteristics, and patient population. Respondents were asked to estimate the number of 
patients who complained about heavy menstrual bleeding each year. Questions were then 
asked about practice patterns regarding evaluation,10 testing, and referral of patients with 
unexplained menorrhagia. Knowledge of VWD among women with menorrhagia was 
assessed. Respondents also rated their medical training in screening, assessment, and 
treatment of menorrhagia.
Statistical analyses were performed using SPSS version 16 (SPSS Inc., Chicago, IL). 
Descriptive data were computed for primary analysis. t tests and χ2 analyses were used for 
inferential statistics; statistical significance was defined at ≤ 05. Because age and sex were 
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associated, we controlled for sex when assessing for differences by age and we controlled 
for age when assessing for differences by sex.
RESULTS
A total of 503 questionnaires were returned for an overall response rate of 42.4% 
(503/1185); 15 questionnaires were excluded because those physicians could not be reached. 
The response rate was 56.7% (338/596) for CARN members and 27.8% (165/589) for non-
CARN members. Differences between CARN and non-CARN were assessed for all 
demographic variables including: age, sex, number of patients seen each week, number of 
patients seen each year, number of deliveries in 2008, number of surgeries in 2008, percent 
of patient races, primary medical specialty, and residency of patients. Because no 
differences were found, the samples were combined for analyses. Of this sample, 451 
indicated that they provide gynecologic services so all analyses were limited to this sample.
Participant and practice characteristics are shown in Table 1. Fifty-one percent of the 
respondents were male. The mean year of birth was 1958; males were significantly older 
than females (1954 vs 1963; P < .001). Forty-eight percent of participants described their 
current practice as an obstetrician-gynecologist partnership or group and 78% reported their 
primary practice as general obstetrician-gynecologist. Seventy-seven percent also perform 
obstetric services. A plurality of respondents reported that 35% of patients resided in a 
suburban area. As shown in Table 1, the average percent of non-Hispanic white patients in 
each respondents’ practice was 61% (standard deviation [SD] = 27%) and the average 
percent of African American patients in each respondents’ practice was 15% (SD = 15%).
The majority of physicians described their training related to screening of menorrhagia as 
either comprehensive (33%) or adequate (58%); physicians responded similarly regarding 
the assessment of menorrhagia (38% and 56%, respectively). Older physicians rated their 
training significantly less adequate than younger physicians (all P < .001 when controlling 
for sex). Training was not rated differently by practice location.
The mean number of patients seen per year was 4156 (SD = 2031). The respondents 
reported that, on average, 198 (4.8%) of their patients complained about menorrhagia each 
year (SD = 321). Physicians indicated the questions they routinely asked patients when 
evaluating unexplained menorrhagia. The length of patients’ periods, limitations of periods 
on daily life, and history of anemia treatment were most commonly asked (100%, 95.3%, 
and 84.9%, respectively). Approximately 74.7% of respondents asked about bleeding 
problems, following delivery or miscarriage, 68.3% asked about family history of bleeding 
disorders, 68.5% asked about bleeding problems after surgery, and 66.7% asked if patients 
experienced sensation of “flooding” or “gushing.” Only 49.0% of physicians routinely asked 
about problems with bleeding after tooth extraction or dental surgery. When controlling for 
sex in a partial correlation, age was significantly correlated with how commonly physicians 
asked about problems with bleeding after tooth extraction or dental surgery (r = 0.159; P = .
001), problems after surgery (r = 0.121; P = .011), and asking about “flooding” or “gushing” 
during periods (r = 0.245; P < .001), with younger obstetrician-gynecologists being less 
likely to ask these questions. Differences were also found based on sex in χ2 analyses when 
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controlling for age. Among the oldest physician group (year of birth 1927-1952), female 
obstetrician-gynecologists were more likely to ask about family history (χ2 = 4.4; P = .027), 
bleeding problems after surgery (χ2 = 6.9; P = .005), and having bleeding problems after 
delivery or miscarriage (χ2 = 6.9; P = .005).
Physicians were asked about the likelihood of ordering specific tests and procedures for 
women who were experiencing heavy or prolonged menstrual bleeding and were (a) 
adolescent patients around the age of menarche (1-2 years after menarche) and (b) patients 
of reproductive age (approximately 15-44 years old) (Table 2). Seventy-seven percent of 
physicians reported that they would be likely or very likely to consider VWD or another 
bleeding disorder as causing menorrhagia in adolescent patients; however, only 36.4% of 
physicians would consider bleeding disorders in reproductive age women with menorrhagia.
Eighty-one percent of respondents reported having seen patients with menorrhagia caused 
by a bleeding disorder. When asked what proportion of patients with menorrhagia are 
referred to other health care providers, 63% of physicians reported referring up to 25% of 
menorrhagia patients for further diagnosis or treatment; 33% of physicians did not refer 
menorrhagia patients to other specialists. Respondents most commonly refer patients to 
hematology (44%) (Table 3).
When asked to estimate the prevalence of VWD among women in the United States with 
menorrhagia, 9.3% indicated “less than 1%,” 52.8% indicated “1-5%,” 25.5% indicated 
“5-10%,” 7.8% indicated “10-15%,” and 2% indicated “15-20%” (2.6% did not answer). 
The US prevalence of VWD among women with menorrhagia as reported by Dilley et al is 
6.6%.11 When asked whether African American women were more likely to have VWD 
(true/false), 88.9% correctly indicated false (7.1% indicate true and 4.0% did not answer).
COMMENT
This survey provides updated insight regarding obstetrician-gynecologist practices on the 
evaluation of unexplained menorrhagia. The current data demonstrate that obstetrician-
gynecologists seem to have a relatively high awareness of VWD and other bleeding 
disorders as potential underlying causes of menorrhagia. The Centers for Disease Control 
and Prevention conducted a similar survey over 10 years ago which demonstrated low 
provider recognition of VWD as a differential diagnosis for menorrhagia.6 At that time, 
respondents perceived the prevalence of VWD among women with menorrhagia to be <1%. 
In fact, 2 European studies had reported prevalence as 13% and 25%, respectively,12,13 and 
a US study reported a similarly high prevalence among non-Hispanic whites.11 Only 9.3% 
of current respondents estimated the prevalence of VWD among women with menorrhagia 
to be less than 1%; however, more than 50% still underestimated the true prevalence. Four 
percent of previous respondents considered VWD in their differential diagnosis of 
reproductive age women with menorrhagia; 16.5% considered VWD for girls near 
menarche.6 In the current survey, nearly 39% and 77% of obstetrician-gynecologists were 
likely to consider VWD or another bleeding disorder among reproductive-age women and 
adolescents, respectively. In the earlier survey, 45% percent of respondents had never seen a 
patient with menorrhagia caused by a bleeding disorder6; our results showed that over 80% 
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of current respondents have seen menorrhagia attributed to a bleeding disorder. The majority 
of respondents from the current survey refer patients with menorrhagia to other health care 
providers for further diagnosis and treatment, with nearly 45% of respondents likely to refer 
to hematology. Previously, only 3% of respondents referred menorrhagia patients to 
specialists.6
Interestingly, a low proportion of current survey respondents regularly asked patients about 
family history of bleeding disorders or bleeding episodes associated with surgery, dental 
procedures, delivery, or miscarriage. A comprehensive bleeding history can determine 
whether a subset of women with menorrhagia is at an increased risk for a bleeding disorder. 
Philipp et al10 assessed the usefulness of a screening questionnaire for obstetrician-
gynecologists to identify at-risk women; 2 of the criteria for a positive screen were family 
history and a history of excessive bleeding with tooth extraction, delivery or miscarriage, or 
surgery. An expert panel recently recommended that women with family history of a 
bleeding disorder and/or personal history of bleeding symptoms should be evaluated for a 
bleeding disorder.14 A study assessing obstetrician-gynecologist residency training in the 
evaluation of menorrhagia demonstrated that chief residents were less likely to ask questions 
about common bleeding risk factors; for example, 66.1% of respondents would ask about 
excessive postsurgical bleeding either less than half of the time or never.15 Additional 
medical education may be needed to increase awareness of risk factors suggestive of 
bleeding disorders.
Nearly 80% of respondents reported that they would likely consider VWD or another 
bleeding disorder as a differential diagnosis in adolescent patients compared with 16.5% in 
the Dilley et al survey.6 Early identification of bleeding symptoms among adolescents is 
important for timely diagnosis and treatment. In a Centers for Disease Control and 
Prevention survey of 75 women with VWD, most women experienced their first bleeding 
symptoms during adolescence but were not diagnosed until 16 years later; the average age at 
diagnosis was 23 years old.16 However, recent surveillance of girls and women with 
bleeding disorders receiving care at US hemophilia treatment centers shows that the average 
age at diagnosis was 15.4 years old and over half of participants were diagnosed by age 
12.17 The current data suggest there may be greater recognition of underlying bleeding 
disorders in a younger population. However, it should be noted that bleeding disorders are 
prevalent among reproductive-age women with menorrhagia18 and less than 40% of current 
respondents were likely to consider bleeding disorders in this population.
This study has inherent limitations. This survey relies on self-reported data from 
obstetrician-gynecologists and responses may represent an estimate rather than objectively 
confirmed data from the respondent’s practice. Although respondents were contacted 
multiple times, the overall response rate was relatively low at 42.4%. These survey data are 
subject to nonresponse bias and obstetrician-gynecologists who chose to respond could be 
intrinsically different from nonresponders. Though the participants represent a small 
proportion of all practicing obstetrician-gynecologists, the sample was quasirandomly 
selected from a sample that includes over 90% of all US obstetrician-gynecologists. Also, 
the majority of respondents are CARN members, a subset of ACOG physicians who 
frequently participate in survey research. However, CARN membership is actively managed 
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to maintain demographic similarity with ACOG Fellows as a whole. Several surveys per 
year include both CARN and non-CARN ACOG Fellows as participants19,20 and 
differences in responses between CARN and non-CARN Fellows have been rare and are 
usually of little consequence. Another potential limitation is that specialty coagulation tests 
such as VWF ristocetin cofactor activity, VWF antigen, and factor VIII activity were not 
included in assessing which tests obstetrician-gynecologists would be likely to order to 
evaluate menorrhagia. However, the inclusion of those tests would not be appropriate for the 
initial evaluation of abnormal or dysfunctional uterine bleeding. Diagnosis of VWD is very 
complex because of a number of factors, including the necessity of multiple and repeat 
laboratory tests and variable interpretation based on a combination of clinical features and 
laboratory evaluation.14 If a bleeding disorder is suspected, close collaboration with or 
referral to a hematologist for further hemostatic evaluation is encouraged.
An overall heightened awareness of bleeding disorders among obstetrician-gynecologists 
may be due to a number of factors. The impact of bleeding disorders on the reproductive 
health of women has been an emerging issue over the last several years. Recent studies have 
highlighted that women with VWD and other bleeding disorders may experience increased 
gynecologic and obstetric morbidity including menorrhagia and postpartum 
hemorrhage.5,21,22 There have been multiple efforts by the research community, hematology 
providers, community-based organizations, and government agencies to raise awareness and 
increase early identification of bleeding disorders in women with menorrhagia. In 2008, the 
National Heart, Lung, and Blood Institute of the National Institutes of Health published 
comprehensive guidelines on the diagnosis, evaluation, and management of VWD, which 
included guidance on issues specific to women.23,24 ACOG subsequently issued a 
committee opinion encouraging obstetrician-gynecologists to consider VWD and other 
bleeding disorders when evaluating patients with menorrhagia.25 Although these data 
suggest a positive change in obstetrician-gynecologist practice, it is important to remain 
vigilant in identifying girls and women at-risk for underlying bleeding disorders. Failure to 
suspect bleeding disorders in patients with menorrhagia may delay diagnosis and treatment 
and subject women to increased morbidity. Consultation and collaboration with a 
hematologist is essential for accurate diagnosis and appropriate management.
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TABLE 1
Respondent characteristics (n = 451)
Characteristic Response No. (%) or Mean (SD)
Mean year of birth 1958 (SD = 10.3) —





Solo practice 85 (19)
Multispecialty group 61 (13)
University full-time faculty and practice 45 (10)
HMO (staff model) 10 (2)
Other 32 (7)
Primary medical specialty General obstetric-gynecology 350 (78)
Gynecology only 76 (17)
Maternal-fetal medicine 4 (1)
Reproductive endocrinology 7 (1)
Obstetrics only 1 (<1)
Other 13 (3)
Residency of patients Suburban 158 (35)
Urban, noninner city 113 (25)







Race/ethnicity of patients Non-Hispanic white 60.5% (SD = 27)
Hispanic 15.7% (SD = 20)
African-American 14.7% (SD = 15)
Asian/Pacific Islander 4.7% (SD = 7.6)
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Characteristic Response No. (%) or Mean (SD)
Native American 1.4% (SD = 7.2)
Other 2.0% (SD = 8.7)
HMO, health maintenance organization; SD, standard deviation.
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TABLE 2
Tests and procedures likely or very likely to be ordered for patients experiencing heavy or prolonged 




Complete blood count 412 (91.4%) 434 (96.2%)
Diagnostic D & C 3 (0.7%) 78 (17.3%)
Endometrial biopsy 7 (1.6%) 337 (74.7%)
Ferritin 187 (41.5%) 237 (52.5%)
Hysteroscopy 10 (2.2%) 234 (51.9%)
Thyroid chemistry 364 (80.7%) 407 (90.2%)
Papanicolaou smear 126 (27.9%) 405 (89.8%)
Ultrasound 294 (65.2%) 420 (93.1%)
D & C, dilation and curettage.
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TABLE 3
Referral patterns to other medical specialties (n = 451)
Medical specialty Likely to refer Unikely to refer
Hematology 199 (44.1%) 245 (54.3%)
Endocrinology 79 (17.5%) 359 (79.6%)
Internal medicine 43 (9.5%) 393 (87.1%)
Oncology 35 (7.8%) 401 (88.9%)
Primary care 27 (6.0%) 409 (90.7%)
Family practice 19 (4.2%) 416 (92.2%)
Responses do not equal 100% because some individuals did not respond.
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